HMRC ends VAT exemption for deputy medical practitioner supplies from May 2027

HMRC is moving to close a long-standing VAT exemption for the supply of a deputy for a registered medical practitioner, a change with direct consequences for medical staffing firms, NHS Trusts, and private healthcare providers that rely on temporary cover. The measure takes effect on and after 1 May 2027, and it reclassifies those supplies as standard rated unless they fall within the narrower category of services consisting of medical care.

The policy turns on a distinction that matters in practice: deputising services that primarily deliver medical care will stay exempt, while the supply of a deputy as staff will not. For hospitals, practices, and agencies, the tax treatment now depends on what is being sold, not only on who performs the work.

Legislation in Finance Bill 2026-27 will amend Group 7 of Schedule 9 to the Value Added Tax Act 1994 by removing Item 5, the exemption for the provision of a deputy for a registered medical practitioner. HMRC describes the change as a return to its previous intended policy position. In plain terms, the exemption is being narrowed so that VAT relief applies to medical care, including deputising services, but not to a supply of staff.

That distinction will matter most for organisations operating in the medical employment services market. Agencies that place deputies, and providers that purchase those services, will need to review contracts, invoicing arrangements, and VAT registration status well before the operative date. Some smaller organisations may need to register for VAT if taxable turnover exceeds the threshold.

One immediate consequence is administrative rather than clinical: accounting systems will need to be reworked to reflect the new tax treatment.

Medical care remains exempt, but staffing supply does not

The policy draws a bright line between a service that constitutes patient-facing medical care and a service that is essentially labour supply. Out-of-hours deputising services, where the deputising arrangement is itself a medical-care service, will continue to be exempt from VAT. By contrast, the supply of a deputy for a registered medical practitioner will be standard rated when it is structured as a staff supply.

That matters for commissioners and providers because the same clinician may sit inside very different commercial arrangements. A sole trader working directly for an NHS Trust or a private practice may, depending on contract terms, be supplying VAT-exempt medical care rather than taxable staff cover. Where the contract does not meet that description, VAT will apply.

The policy does not change access to care, and it does not alter the underlying clinical service delivered to patients. It changes how the service is classified for tax purposes, which is why providers must separate operational continuity from tax treatment when they plan locum cover or deputising arrangements.

NHS bodies face little direct burden, while agencies absorb the main cost

HMRC expects only a negligible administrative impact on NHS bodies and private healthcare providers. The heavier burden falls on employment businesses and other organisations that supply deputies for medical practitioners. For those firms, the measure removes the VAT exemption and ends partial exemption status for some businesses.

Estimated one-off costs across affected businesses total £7 million. Those costs include familiarisation with the rule change, updates to accounting software, changes to invoicing software, and VAT registration for some smaller organisations. The continuing annual administrative impact is expected to be negligible overall, with estimated savings of £100,000 offsetting costs and leaving the net annual burden negligible.

The cash flow effect may still be felt more sharply than the aggregate figures suggest. Firms newly required to account for VAT will need to alter pricing models, revisit contract terms, and ensure invoices reflect the correct treatment from day one of the new regime.

Exchequer gains rise steadily after implementation

The policy is projected to generate increasing revenue for the Exchequer once it takes effect. The fiscal impact is listed at £85 million in 2027 to 2028, rising to £95 million in 2028 to 2029, £100 million in 2029 to 2030, £100 million in 2030 to 2031, and £105 million in 2031 to 2032. Those figures are certified by the Office for Budget Responsibility and appear in Table 6.1 of Budget 2026.

The economic assessment anticipates no significant macroeconomic effects. In practical terms, the measure is designed as a classification correction rather than a structural intervention in healthcare delivery. It does not change staffing levels on the ward, the availability of on-call cover, or the clinical qualifications required of a deputy.

Contract design will determine whether VAT applies

For medical employers, the key issue is contractual form. Direct supplies of a deputy to a healthcare provider may now be taxable, while services that are genuinely medical care remain exempt. This means contract language, billing pathways, and the substance of the arrangement will all need to be reviewed with precision.

Smaller agencies may feel the administrative consequences first. VAT registration, invoice redesign, and quarterly reporting all become part of the operating model once the threshold is crossed. Some of the stated savings come from ending partial exemption calculations and simplifying tax accounting, but those savings are modest compared with the initial adaptation costs.

The measure also carries an important boundary for clinicians working through agencies or as sole traders. The tax outcome will not be determined by title alone. It will depend on whether the arrangement is treated as medical care or as supply of staff.

Monitoring will rely on routine VAT reporting

HMRC plans to monitor the change through existing VAT reporting and compliance processes. No special monitoring system is proposed, and HMRC does not expect significant operational costs in implementation. Equalities impacts have been considered, though HMRC does not hold data that would allow assessment of disproportionate effects on protected groups.

For healthcare systems, the operational task is straightforward but unavoidable: identify which deputy arrangements remain exempt, identify which become standard rated, and adjust contracts before the May 2027 start date. The policy gives providers more than a year to prepare, but the boundary between medical care and staff supply will need careful legal and accounting review long before the rule changes take effect.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by MHRA (UK) Official Updates.